Harvard Management Company, which oversees Harvard University's endowment, has disclosed a $2.2 billion stake in SpaceX, revealing how deeply one of the world's largest institutional investors bet on Elon Musk's rocket company years before it ever traded publicly. The position, made public in a fresh quarterly disclosure, spans 12,935,100 shares valued at roughly $2.21 billion as of June 30.
The stake alone accounts for more than half of the approximately $4.3 billion in U.S. equities Harvard's fund disclosed in the filing, and is worth more than every other reported holding in the portfolio combined. The next-largest position, a roughly $350 million stake in Taiwan Semiconductor Manufacturing Company, is barely a sixth the size of the SpaceX bet.
A Decade-Old Bet Pays Off
Harvard's position traces back to a venture investment made more than ten years ago, when SpaceX was valued at around $12 billion — a fraction of the valuation it commands today. That early conviction converted into a publicly tradable windfall when SpaceX priced its initial public offering at $135 per share on June 11, 2026, selling 555,555,555 Class A shares before underwriters fully exercised their overallotment option, pushing the total offering to 638,888,888 shares. Trading opened on Nasdaq under the ticker SPCX on June 12, in what ranks as the largest IPO in history.
Related: Tokenized Stock Holders Double to 1.31M as Volume Surges 179%
An Endowment Playbook Built on Concentration
Harvard's disclosure fits a broader pattern among sophisticated early SpaceX backers: rather than trimming the position as it grew, funds that got in during the company's private years have largely let their stakes ride, betting that a company controlling the majority of global orbital launch capacity still has room to compound. That conviction isn't unique to Harvard — venture firm Thrive Capital's own latest disclosure showed SpaceX making up nearly 85% of its public equity book, an even more concentrated bet than Harvard's.
The IPO has also reshaped how retail investors without access to Harvard-style private allocations can get exposure to the company. In the run-up to SpaceX's listing, several crypto exchanges rushed to offer tokenized SpaceX products, letting retail traders buy synthetic exposure to shares they otherwise had no way of holding — a scramble that has since become one of the more visible test cases for how tokenized equities perform once the underlying company actually goes public.
What It Signals for Institutional Crypto-Adjacent Bets
Harvard's filing offers a useful data point for the broader debate over whether traditional endowments are becoming more willing to hold concentrated, high-conviction private-to-public positions rather than diversify across index-like baskets. A stake this size, held for over a decade before any liquidity existed, suggests some institutions are comfortable tying up capital in illiquid bets for years in exchange for outsized returns once a listing event finally arrives — the same logic increasingly driving institutional interest in pre-IPO crypto and tokenization plays.
